Ascend Wellness Holdings (AAWH) Cash from Operations Growth (1y) (2021 - 2026)
Ascend Wellness Holdings (AAWH) Cash from Operations Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 81.06% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 8.26% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -46.22% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 63.59% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 73.78% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 33.73% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 16.88% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | 26.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.12% |
| Mar 31, 2026 | -426.84% |
| Dec 31, 2025 | -53.60% |
| Sep 30, 2025 | -201.57% |
| Jun 30, 2025 | -44.81% |
| Mar 31, 2025 | 52.28% |
| Dec 31, 2024 | 110.98% |
| Sep 30, 2024 | -92.83% |
| Jun 30, 2024 | 27.00% |
| Mar 31, 2024 | -32.50% |
| Dec 31, 2023 | 203.71% |
| Sep 30, 2023 | 1,644.44% |
| Jun 30, 2023 | 347.53% |
| Mar 31, 2023 | 156.40% |
| Dec 31, 2022 | 17.35% |
| Sep 30, 2022 | 82.62% |
| Jun 30, 2022 | -142.78% |
| Mar 31, 2022 | -30.86% |
| Dec 31, 2021 | -5,686.90% |
| Sep 30, 2021 | -95.77% |